Acute sinusitis and Hyperventilation

Summary:

Hyperventilation is found among people with Acute sinusitis, especially for people who are female, 50-59 old.

The study analyzes which people have Hyperventilation with Acute sinusitis. It is created by eHealthMe based on reports of 27 people who have Acute sinusitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Acute sinusitis?

Acute sinusitis is found to be associated with 3,123 drugs and 2,741 conditions by eHealthMe. Check the latest studies of Acute sinusitis.

What is Hyperventilation?

Hyperventilation is found to be associated with 791 drugs and 1,442 conditions by eHealthMe. Check the latest studies of Hyperventilation.



On Jan, 25, 2026

27 people who have Acute Sinusitis and Hyperventilation are studied.

Would you have Hyperventilation when you have Acute sinusitis?

Gender of people who have Acute Sinusitis and experienced Hyperventilation *:

  • female: 77.78 %
  • male: 22.22 %

Age of people who have Acute Sinusitis and experienced Hyperventilation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 13.04 %
  • 30-39: 17.39 %
  • 40-49: 21.74 %
  • 50-59: 34.78 %
  • 60+: 13.04 %

Common co-existing conditions for these people *:

  1. Pneumonia: 2 people, 7.41%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 7.41%
  3. Upper-Airway Cough Syndrome: 1 person, 3.70%
  4. Type 2 Diabetes: 1 person, 3.70%
  5. Sinus Disorder (disease of sinus): 1 person, 3.70%
  6. Sinus Congestion (blockage of sinus): 1 person, 3.70%
  7. Hypersensitivity: 1 person, 3.70%
  8. Asthma: 1 person, 3.70%
  9. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 3.70%

Common drugs taken by these people *:

  1. Avelox: 10 people, 37.04%
  2. Avalide: 5 people, 18.52%
  3. Semprex-D: 5 people, 18.52%
  4. Nasonex: 5 people, 18.52%
  5. Levaquin: 3 people, 11.11%
  6. Ketek: 2 people, 7.41%
  7. Cefuroxime: 2 people, 7.41%
  8. Zyrtec: 1 person, 3.70%
  9. Doxycycline: 1 person, 3.70%
  10. Benicar: 1 person, 3.70%

Common symptoms for these people *:

  1. Dyspnea (difficult or laboured breathing): 11 people, 40.74%
  2. Dizziness: 10 people, 37.04%
  3. Abdominal Pain: 8 people, 29.63%
  4. Stress And Anxiety: 7 people, 25.93%
  5. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 7 people, 25.93%
  6. Pruritus Generalised (generalized itching): 7 people, 25.93%
  7. Chills (felling of cold): 6 people, 22.22%
  8. Rash Erythematous (redness of the skin): 6 people, 22.22%
  9. Wheezing (a high-pitched whistling sound made while you breath): 6 people, 22.22%
  10. Throat Irritation: 5 people, 18.52%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hyperventilation:

All the conditions that are associated with Hyperventilation:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperventilation and Acute sinusitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: